AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $2.09M invested in AIM ImmunoTech in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$76K
2
+$61.4K
3
+$25K

Top Sellers

1
-$30K
2
-$25.2K
3
-$13.6K
4
Goldman Sachs
Goldman Sachs
New York
-$5K
5
CS
Credit Suisse
Switzerland
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$856K
2
$522K
3
$189K
4
$133K
5
$86K
6
$76K
7
$68K
8
$57K
9
$25K
10
$21K
11
$15K
12
$13K
13
$7K
14
$7K
15
$5K
16
$3K
17
$2K
18
$2K
19
$2K
20
–
21
–
22
–
23
–